Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders
Author:
Funder
Takeda Science Foundation
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00277-020-04084-5.pdf
Reference44 articles.
1. Dierickx D, Tousseyn T, Gheysens O (2015) How i treat posttransplant lymphoproliferative disorders. Blood 126(20):2274–2283
2. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J (2002) Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 99(11):3909–3915
3. Hasserjian RP, Chen S, Perkins SL, de Leval L, Kinney MC, Barry TS, Said J, Lim MS, Finn WG, Medeiros LJ, Harris NL, O'Malley DP (2009) Immunomodulator agent-related lymphoproliferative disorders. Mod Pathol 22(12):1532–1540
4. Chetty R, Biddolph SC, Kaklamanis L et al (1996) EBV latent membrane protein (LMP-1) and bcl-2 protein expression in Reed-Sternberg-like cells in post-transplant lymphoproliferative disorders. Histopathology 28(3):257–260
5. Stevens SJC, Verschuuren EAM, Pronk I, van der Bij W, Harmsen MC, The TH, Meijer CJLM, van den Brule AJC, Middeldorp JM (2001) Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood 97(5):1165–1171
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Retrospective analyses of other iatrogenic immunodeficiency‐associated lymphoproliferative disorders in patients with rheumatic diseases;British Journal of Haematology;2021-09-23
2. Distinct immunopathological mechanisms of EBV‐positive and EBV‐negative posttransplant lymphoproliferative disorders;American Journal of Transplantation;2021-06-17
3. The clinical efficacy of Rituximab administration in autoimmunity disorders, primary immunodeficiency diseases and malignancies;International Immunopharmacology;2021-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3